IBDEI0EX ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18859,1,3,0)
 ;;=3^Speech/Lang Deficit Following Cerebvasc Infarc
 ;;^UTILITY(U,$J,358.3,18859,1,4,0)
 ;;=4^I69.328
 ;;^UTILITY(U,$J,358.3,18859,2)
 ;;=^5007495
 ;;^UTILITY(U,$J,358.3,18860,0)
 ;;=E04.0^^55^780^39
 ;;^UTILITY(U,$J,358.3,18860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18860,1,3,0)
 ;;=3^Nontoxic Diffuse Goiter
 ;;^UTILITY(U,$J,358.3,18860,1,4,0)
 ;;=4^E04.0
 ;;^UTILITY(U,$J,358.3,18860,2)
 ;;=^5002477
 ;;^UTILITY(U,$J,358.3,18861,0)
 ;;=E04.1^^55^780^41
 ;;^UTILITY(U,$J,358.3,18861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18861,1,3,0)
 ;;=3^Nontoxic Single Thyroid Nodule
 ;;^UTILITY(U,$J,358.3,18861,1,4,0)
 ;;=4^E04.1
 ;;^UTILITY(U,$J,358.3,18861,2)
 ;;=^5002478
 ;;^UTILITY(U,$J,358.3,18862,0)
 ;;=E04.2^^55^780^40
 ;;^UTILITY(U,$J,358.3,18862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18862,1,3,0)
 ;;=3^Nontoxic Multinodular Goiter
 ;;^UTILITY(U,$J,358.3,18862,1,4,0)
 ;;=4^E04.2
 ;;^UTILITY(U,$J,358.3,18862,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,18863,0)
 ;;=E01.1^^55^780^36
 ;;^UTILITY(U,$J,358.3,18863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18863,1,3,0)
 ;;=3^Iodine-Deficiency Related Multinodular (Endemic) Goiter
 ;;^UTILITY(U,$J,358.3,18863,1,4,0)
 ;;=4^E01.1
 ;;^UTILITY(U,$J,358.3,18863,2)
 ;;=^5002465
 ;;^UTILITY(U,$J,358.3,18864,0)
 ;;=E05.00^^55^780^56
 ;;^UTILITY(U,$J,358.3,18864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18864,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/o Thyrotoxic Crisis
 ;;^UTILITY(U,$J,358.3,18864,1,4,0)
 ;;=4^E05.00
 ;;^UTILITY(U,$J,358.3,18864,2)
 ;;=^5002481
 ;;^UTILITY(U,$J,358.3,18865,0)
 ;;=E05.01^^55^780^55
 ;;^UTILITY(U,$J,358.3,18865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18865,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,18865,1,4,0)
 ;;=4^E05.01
 ;;^UTILITY(U,$J,358.3,18865,2)
 ;;=^5002482
 ;;^UTILITY(U,$J,358.3,18866,0)
 ;;=E05.90^^55^780^58
 ;;^UTILITY(U,$J,358.3,18866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18866,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/o Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,18866,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,18866,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,18867,0)
 ;;=E05.91^^55^780^57
 ;;^UTILITY(U,$J,358.3,18867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18867,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,18867,1,4,0)
 ;;=4^E05.91
 ;;^UTILITY(U,$J,358.3,18867,2)
 ;;=^5002493
 ;;^UTILITY(U,$J,358.3,18868,0)
 ;;=E89.0^^55^780^50
 ;;^UTILITY(U,$J,358.3,18868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18868,1,3,0)
 ;;=3^Postprocedural Hypothyroidism
 ;;^UTILITY(U,$J,358.3,18868,1,4,0)
 ;;=4^E89.0
 ;;^UTILITY(U,$J,358.3,18868,2)
 ;;=^5003035
 ;;^UTILITY(U,$J,358.3,18869,0)
 ;;=E03.2^^55^780^32
 ;;^UTILITY(U,$J,358.3,18869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18869,1,3,0)
 ;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances
 ;;^UTILITY(U,$J,358.3,18869,1,4,0)
 ;;=4^E03.2
 ;;^UTILITY(U,$J,358.3,18869,2)
 ;;=^5002471
 ;;^UTILITY(U,$J,358.3,18870,0)
 ;;=E03.9^^55^780^33
 ;;^UTILITY(U,$J,358.3,18870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18870,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,18870,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,18870,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,18871,0)
 ;;=E06.0^^55^780^53
 ;;^UTILITY(U,$J,358.3,18871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18871,1,3,0)
 ;;=3^Thyroiditis,Acute
 ;;^UTILITY(U,$J,358.3,18871,1,4,0)
 ;;=4^E06.0
 ;;^UTILITY(U,$J,358.3,18871,2)
 ;;=^2692
 ;;^UTILITY(U,$J,358.3,18872,0)
 ;;=E06.1^^55^780^54
 ;;^UTILITY(U,$J,358.3,18872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18872,1,3,0)
 ;;=3^Thyroiditis,Subacute
 ;;^UTILITY(U,$J,358.3,18872,1,4,0)
 ;;=4^E06.1
 ;;^UTILITY(U,$J,358.3,18872,2)
 ;;=^119376
 ;;^UTILITY(U,$J,358.3,18873,0)
 ;;=C73.^^55^780^37
 ;;^UTILITY(U,$J,358.3,18873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18873,1,3,0)
 ;;=3^Malig Neop of Thyroid Gland
 ;;^UTILITY(U,$J,358.3,18873,1,4,0)
 ;;=4^C73.
 ;;^UTILITY(U,$J,358.3,18873,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,18874,0)
 ;;=E10.21^^55^780^8
 ;;^UTILITY(U,$J,358.3,18874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18874,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,18874,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,18874,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,18875,0)
 ;;=E10.9^^55^780^12
 ;;^UTILITY(U,$J,358.3,18875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18875,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,18875,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,18875,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,18876,0)
 ;;=E11.21^^55^780^17
 ;;^UTILITY(U,$J,358.3,18876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18876,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,18876,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,18876,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,18877,0)
 ;;=E11.39^^55^780^18
 ;;^UTILITY(U,$J,358.3,18877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18877,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complication NEC
 ;;^UTILITY(U,$J,358.3,18877,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,18877,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,18878,0)
 ;;=E11.43^^55^780^15
 ;;^UTILITY(U,$J,358.3,18878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18878,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Autonomic Neuropathy
 ;;^UTILITY(U,$J,358.3,18878,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,18878,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,18879,0)
 ;;=E11.59^^55^780^13
 ;;^UTILITY(U,$J,358.3,18879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18879,1,3,0)
 ;;=3^DM Type 2 w/ Circulatory Complications NEC
 ;;^UTILITY(U,$J,358.3,18879,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,18879,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,18880,0)
 ;;=E11.618^^55^780^14
 ;;^UTILITY(U,$J,358.3,18880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18880,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Arthropathy NEC
 ;;^UTILITY(U,$J,358.3,18880,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,18880,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,18881,0)
 ;;=E11.621^^55^780^16
 ;;^UTILITY(U,$J,358.3,18881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18881,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,18881,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,18881,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,18882,0)
 ;;=E11.622^^55^780^20
 ;;^UTILITY(U,$J,358.3,18882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18882,1,3,0)
 ;;=3^DM Type 2 w/ Skin Ulcer NEC
 ;;^UTILITY(U,$J,358.3,18882,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,18882,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,18883,0)
 ;;=E11.65^^55^780^19
 ;;^UTILITY(U,$J,358.3,18883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18883,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,18883,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,18883,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,18884,0)
 ;;=E11.9^^55^780^21
 ;;^UTILITY(U,$J,358.3,18884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18884,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,18884,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,18884,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,18885,0)
 ;;=E13.9^^55^780^22
 ;;^UTILITY(U,$J,358.3,18885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18885,1,3,0)
 ;;=3^Diabetes Mellitus (Secondary) w/o Complications NEC
 ;;^UTILITY(U,$J,358.3,18885,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,18885,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,18886,0)
 ;;=E16.2^^55^780^29
 ;;^UTILITY(U,$J,358.3,18886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18886,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,18886,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,18886,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,18887,0)
 ;;=E20.0^^55^780^34
 ;;^UTILITY(U,$J,358.3,18887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18887,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,18887,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,18887,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,18888,0)
 ;;=E20.9^^55^780^30
 ;;^UTILITY(U,$J,358.3,18888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18888,1,3,0)
 ;;=3^Hypoparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,18888,1,4,0)
 ;;=4^E20.9
 ;;^UTILITY(U,$J,358.3,18888,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,18889,0)
 ;;=E23.0^^55^780^31
 ;;^UTILITY(U,$J,358.3,18889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18889,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,18889,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,18889,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,18890,0)
 ;;=E27.1^^55^780^51
 ;;^UTILITY(U,$J,358.3,18890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18890,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,18890,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,18890,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,18891,0)
 ;;=E27.2^^55^780^1
 ;;^UTILITY(U,$J,358.3,18891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18891,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,18891,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,18891,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,18892,0)
 ;;=E27.3^^55^780^23
 ;;^UTILITY(U,$J,358.3,18892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18892,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,18892,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,18892,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,18893,0)
 ;;=E29.1^^55^780^52
 ;;^UTILITY(U,$J,358.3,18893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18893,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,18893,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,18893,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,18894,0)
 ;;=E55.9^^55^780^59
 ;;^UTILITY(U,$J,358.3,18894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18894,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,18894,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,18894,2)
 ;;=^5002799
